Ruklanthi de Alwis Selected Research

Ruklanthi de Alwis Research Topics

12	Infections 01/2019 - 03/2010
9	Dengue (Dengue Fever) 05/2016 - 03/2010
5	COVID-19 02/2022 - 05/2020
3	Severe Dengue 01/2016 - 06/2013
2	Yellow Fever 01/2020 - 01/2020
2	Typhoid Fever (Typhoid) 01/2018 - 07/2017
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Fatigue 01/2022
1	Mosquito-Borne Diseases 11/2021
1	Measles 11/2021
1	Acute Disease 11/2021
1	Bacillary Dysentery (Shigellosis) 01/2021
1	Diarrhea 01/2018
1	Coinfection 01/2016
1	Virus Diseases (Viral Diseases) 10/2014
1	Human Influenza (Influenza) 02/2014

9	VaccinesIBA 02/2022 - 06/2013
9	AntibodiesIBA 01/2019 - 06/2011
7	Neutralizing AntibodiesIBA 05/2016 - 03/2010
6	EpitopesIBA 05/2016 - 03/2010
4	AntigensIBA 01/2021 - 06/2013
4	Monoclonal AntibodiesIBA 01/2016 - 03/2010
3	Proteins (Proteins, Gene)FDA Link 05/2016 - 05/2012
2	Fc Receptors (Fc Receptor)IBA 01/2016 - 06/2011
2	Blocking AntibodiesIBA 01/2016 - 10/2014
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 05/2022
1	Ad26COVS1IBA 02/2022
1	BNT162 VaccineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	SolutionsIBA 01/2022
1	Explosive Agents (Explosives)IBA 11/2021
1	mRNA VaccinesIBA 11/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CytokinesIBA 01/2021
1	GlobulinsIBA 05/2020
1	Antiviral Agents (Antivirals)IBA 05/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 07/2017
1	Immune Sera (Antisera)IBA 10/2014
1	Viral AntigensIBA 10/2014
1	Immunoglobulin Fab FragmentsIBA 10/2014
1	Dengue VaccinesIBA 06/2013

4	Therapeutics 05/2020 - 01/2018
1	Bathroom Equipment 01/2018